1.
Clin Exp Dermatol
; 47(2): 443, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1570537
Subject(s)
COVID-19 , Interferon Type I , Psoriasis , COVID-19 Vaccines , Humans , Psoriasis/chemically induced , SARS-CoV-2
2.
Clin Exp Dermatol
; 47(2): 436-437, 2022 02.
Article
in English
| MEDLINE | ID: covidwho-1470380
3.
Clinical and Experimental Dermatology
; n/a(n/a), 2021.
Article
in English
| Wiley | ID: covidwho-1408678
ABSTRACT
Abstract We read with interest the article entitled ?Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?? by Aktas et al.1 The authors describe a 58-year-old man with ulcerative colitis who developed symmetrically distributed vitiligo facial patches around one week after receiving first dose of mRNA vaccine.1 the authors then ponder on the possible underlying immunological mechanism.